Scholar Commons
metadata only
Comparing Sodium-Glucose cotransporter-2 Inhibitors (SGLT2i) versus Inhibitors of the renin-angiotensin system (RASi) In Heart Failure Patients with Alzheimers Disease and Related Dementia (ADRD)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mechanisms and Reversibility of Heart Failure Associated With Diabetes#851308
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease#1137674
- Dapagliflozin With or Without Spironolactone for HFpEF#969596
- Effect of Sacubitril-Valsartan on Cardiac Structure and Function#824958
- Sodium Glucose Co-Transporter-2 inhibitors in patients with systemic sclerosis with or without heart failure.#295501
Record · ID 323897
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive